Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Colon to Rectum

    Lyophilized oral fecal microbiota transplantation for ulcerative colitis (LOTUS): A randomized, double-blind, placebo-controlled trial

    Lancet Gastroenterol Hepatol. 2022;7(2):141–51

    Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW

    Go to article

    Colon to Rectum

    Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumor necrosis factor inhibitors (HICKORY): A phase 3, randomized, controlled trial

    Lancet Gastroenterol Hepatol. 2022;7(2):128–40

    Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group

    Go to article

    Colon to Rectum

    Efficacy and safety of tofacitinib in ulcerative colitis based on prior tumor necrosis factor inhibitor failure status

    Clin Gastroenterol Hepatol. 2022;20(3):591–601.e8

    Sandborn WJ, Peyrin-Biroulet L, Sharara AI, Su C, Modesto I, Mundayat R, Gunay LM, Salese L, Sands BE

    Go to article

    Colon to Rectum

    Anti-TNF therapy and the risk of herpes zoster among patients with inflammatory bowel disease

    Inflamm Bowel Dis. 2022;28(2):176–82

    Santella C, Bitton A, Filliter C, Bessissow T, Vutcovici M, Lakatos PL, Brassard P

    Go to article

    Colon to Rectum

    Anti-tumor necrosis factor-α withdrawal in children with inflammatory bowel disease in endoscopic and histologic remission

    Inflamm Bowel Dis. 2022;28(2):183–91

    Scarallo L, Bolasco G, Barp J, Bianconi M, di Paola M, Di Toma M, Naldini S, Paci M, Renzo S, Labriola F, De Masi S, Alvisi P, Lionetti P

    Go to article

    Colon to Rectum

    High prevalence of ulcerative appendicitis in patients with ulcerative colitis

    United European Gastroenterol J. 2021;9(10):1148–56

    Heuthorst L, Mookhoek A, Wildenberg ME, D’Haens GR, Bemelman WA, Buskens CJ

    Go to article

    Colon to Rectum

    Transmural response and transmural healing defined by intestinal ultrasound: New potential therapeutic targets?

    J Crohns Colitis. 2022;16(1):57–67

    Helwig U, Fischer I, Hammer L, Kolterer S, Rath S, Maaser C, Kucharzik T; TRUST study group

    Go to article

    Colon to Rectum

    Ultra-proactive therapeutic drug monitoring of infliximab based on point of care testing in inflammatory bowel disease: Results of a pragmatic trial

    J Crohns Colitis. 2022;16(2):199–206

    Bossuyt P, Pouillon L, Claeys S, D’Haens S, Hoefkens E, Strubbe B, Marichal D, Peeters H

    Go to article

    Colon to Rectum

    Long-term colorectal cancer incidence and mortality after adenoma removal in women and men

    Aliment Pharmacol Ther. 2022;55(4):412–21

    Jodal HC, Klotz D, Herfindal M, Barua I, Tag P, Helsingen LM, Refsum E, Holme Ø, Adami HO, Bretthauer M, Kalager M, Løberg M

    Go to article